MOG and encephalitis: Such studies will have a very positive clinical impact, particularly in guiding clinicians towards considering M. pneumoniae as a possible etiological factor in cases of unexplained encephalitis with positive MOG antibodies, which could advance the potential benefits of combining early immunotherapy and anti-M.